Tag Archives: Matthew Sharpe CFA

Leidos Holdings (LDOS) Receives a Hold from Morgan Stanley

Morgan Stanley analyst Matthew Sharpe CFA maintained a Hold rating on Leidos Holdings (LDOS – Research Report) today and set a price target of $83.00. The company’s shares closed last Monday at $83.09, close to its 52-week high of $89.00.

Morgan Stanley Remains a Buy on Booz Allen (BAH)

In a report released today, Matthew Sharpe CFA from Morgan Stanley maintained a Buy rating on Booz Allen (BAH – Research Report), with a price target of $78.00. The company’s shares closed last Monday at $70.85. According to TipRanks.com, CFA

Morgan Stanley Sticks to Its Hold Rating for Leidos Holdings (LDOS)

In a report released today, Matthew Sharpe CFA from Morgan Stanley maintained a Hold rating on Leidos Holdings (LDOS – Research Report), with a price target of $81. The company’s shares closed last Monday at $84.47, close to its 52-week

Morgan Stanley Keeps Their Buy Rating on Science Applications (SAIC)

Morgan Stanley analyst Matthew Sharpe CFA reiterated a Buy rating on Science Applications (SAIC – Research Report) on June 7 and set a price target of $96. The company’s shares closed yesterday at $84.90. According to TipRanks.com, CFA is a